NMR-based plant metabolomics: where do we stand, where do we go?

被引:269
作者
Kim, Hye Kyong [1 ]
Choi, Young Hae [1 ]
Verpoorte, Robert [1 ]
机构
[1] Leiden Univ, Inst Biol, Sect Metabol, NL-2300 RA Leiden, Netherlands
关键词
MAGNETIC-RESONANCE-SPECTROSCOPY; IONIC LIQUIDS; H-1-NMR SPECTROSCOPY; QUALITY-CONTROL; IDENTIFICATION; CLASSIFICATION; EXTRACTS; METABONOMICS; METABOLITES; RESISTANCE;
D O I
10.1016/j.tibtech.2011.02.001
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
NMR-based metabolomics is an important tool for studying biological systems and has been applied in various organisms, including animals, plants and microbes. NMR is able to provide a 'holistic view' of the metabolites under certain conditions, and thus is advantageous for metabolomic studies. To maximize the use of the information obtained, it is also important to create a platform to measure, store and share data. Public databases for storing and sharing information are still lacking for NMR-based metabolomic analysis in plants. Such databases are urgently needed to make metabolic profiling a real omics technology. In addition, to understand metabolic processes in depth, single-cell analysis and the turnover of metabolites in pathways (fluxomics) should be measured.
引用
收藏
页码:267 / 275
页数:9
相关论文
共 50 条
[21]   Functional imaging: where do we go from here? [J].
Kuhnt, D. ;
Bauer, M. H. A. ;
Ganslandt, O. ;
Nimsky, C. .
JOURNAL OF NEUROSURGICAL SCIENCES, 2013, 57 (01) :1-11
[22]   A Hundred Years of Diagnosing Superficial Fungal Infections: Where Do We Come From, Where Are We Now and Where Would We Like To Go? [J].
Graeser, Yvonne ;
Saunte, Ditte Marie Lindhardt .
ACTA DERMATO-VENEREOLOGICA, 2020, 100 :216-224
[23]   Computational advancements to facilitate therapeutic application of phytochemicals: Where do we stand? [J].
Ghosh, Soumyadip ;
Basu, Soumya ;
Kayal, Titirsha ;
Ashok, Gayathri ;
Ramaiah, Sudha ;
Anbarasu, Anand .
DISCOVER APPLIED SCIENCES, 2025, 7 (05)
[24]   Noninvasive biomarkers for lung cancer diagnosis, where do we stand? [J].
Kammer, Michael N. ;
Massion, Pierre P. .
JOURNAL OF THORACIC DISEASE, 2020, 12 (06) :3317-3330
[25]   Quality control in nucleic acid testing - where do we stand? [J].
Valentine-Thon, E .
JOURNAL OF CLINICAL VIROLOGY, 2002, 25 :S13-S21
[26]   High-resolution MS in regulated bioanalysis: where are we now and where do we go from here? [J].
Fung, Eliza N. ;
Jemal, Mohammed ;
Aubry, Anne-Francoise .
BIOANALYSIS, 2013, 5 (10) :1277-1284
[27]   Combination Therapy for Pseudomonas aeruginosa Bacteremia: Where Do We Stand? [J].
Paul, Mical ;
Leibovici, Leonard .
CLINICAL INFECTIOUS DISEASES, 2013, 57 (02) :217-220
[28]   Targeting ubiquitination machinery in cystic fibrosis: Where do we stand? [J].
Okiyoneda, Tsukasa ;
Borgo, Christian ;
Travain, Valentina Bosello ;
Pedemonte, Nicoletta ;
Salvi, Mauro .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2024, 81 (01)
[29]   Pediatric Headache: Where Have We Been and Where Do We Need to Be [J].
Singhi, Samata ;
Jacobs, Howard ;
Gladstein, Jack .
HEADACHE, 2014, 54 (05) :817-829
[30]   Plant root plasticity during drought and recovery: What do we know and where to go? [J].
Zheng, Congcong ;
Bochmann, Helena ;
Liu, Zhaogang ;
Kant, Josefine ;
Schrey, Silvia D. ;
Wojciechowski, Tobias ;
Postma, Johannes Auke .
FRONTIERS IN PLANT SCIENCE, 2023, 14